Greenwood Gearhart’s 89bio ETNB Stock Holding History

Greenwood Gearhart’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-577	Closed	-$6.45K	–	156
2023 Q4	$6.45K	Buy	+577	New	+$5.3K	﹤0.01%	245

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Greenwood Gearhart's ETNB Position: Q1 2024 in Review

Greenwood Gearhart sold out of 89bio (ETNB) in Q1 2024, closing a stake of 577 shares — an estimated $6.45K sold.

Greenwood Gearhart first reported a position in ETNB in Q4 2023 and held it in 1 quarter. The position peaked at $6.45K in Q4 2023. 150 funds tracked by Wall St. Rank hold ETNB as of Q1 2024.

Greenwood Gearhart reported no remaining 89bio position as of Q1 2024 after selling out during the quarter.
Greenwood Gearhart sold 577 89bio shares in Q1 2024, an estimated $6.45K.
Greenwood Gearhart first reported a position in 89bio in Q4 2023 and held it in 1 quarter.
Greenwood Gearhart's 89bio position peaked at $6.45K in Q4 2023.
150 funds tracked by Wall St. Rank held 89bio as of Q1 2024.

Based on Greenwood Gearhart's 13F filing for Q1 2024, filed 15 May 2024.